WallStreetZenWallStreetZen

NASDAQ: ALVR
Allovir Inc Stock Forecast, Predictions & Price Target

Analyst price target for ALVR

Based on 3 analysts offering 12 month price targets for Allovir Inc.
Min Forecast
$1.00+32.45%
Avg Forecast
$1.17+54.57%
Max Forecast
$1.50+98.68%

Should I buy or sell ALVR stock?

Based on 3 analysts offering ratings for Allovir Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
1 analysts 33.33%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALVR stock forecasts and price targets.

ALVR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-26
lockedlocked$00.00+00.00%2023-12-22
lockedlocked$00.00+00.00%2023-12-22

1 of 1

Forecast return on equity

Is ALVR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is ALVR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ALVR revenue forecast

What is ALVR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$64.4M
Avg 2 year Forecast
$177.1M
Avg 3 year Forecast
$320.5M

ALVR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALVR$0.76$1.17+54.57%Hold
TPST$3.91$25.00+539.39%Strong Buy
BTAI$2.82$7.25+157.09%Strong Buy
CRVS$1.78$5.25+194.94%Buy
PMVP$1.70$6.00+252.94%Strong Buy

Allovir Stock Forecast FAQ

Is Allovir Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ALVR) stock is to Hold ALVR stock.

Out of 3 analysts, 0 (0%) are recommending ALVR as a Strong Buy, 0 (0%) are recommending ALVR as a Buy, 2 (66.67%) are recommending ALVR as a Hold, 1 (33.33%) are recommending ALVR as a Sell, and 0 (0%) are recommending ALVR as a Strong Sell.

If you're new to stock investing, here's how to buy Allovir stock.

What is ALVR's revenue growth forecast for 2024-2026?

(NASDAQ: ALVR) Allovir's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Allovir's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ALVR's revenue for 2024 to be $7,394,703,141, with the lowest ALVR revenue forecast at $7,394,703,141, and the highest ALVR revenue forecast at $7,394,703,141. On average, 1 Wall Street analysts forecast ALVR's revenue for 2025 to be $20,340,574,032, with the lowest ALVR revenue forecast at $20,340,574,032, and the highest ALVR revenue forecast at $20,340,574,032.

In 2026, ALVR is forecast to generate $36,812,124,512 in revenue, with the lowest revenue forecast at $36,812,124,512 and the highest revenue forecast at $36,812,124,512.

What is ALVR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALVR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ALVR's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ALVR price target, the average ALVR price target is $1.17, with the highest ALVR stock price forecast at $1.50 and the lowest ALVR stock price forecast at $1.00.

On average, Wall Street analysts predict that Allovir's share price could reach $1.17 by Dec 26, 2024. The average Allovir stock price prediction forecasts a potential upside of 54.57% from the current ALVR share price of $0.76.

What is ALVR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALVR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.